UnknownNot Applicable

Feasibility and Impact of Online HIV/STI Screening Addressed to PrEP Users in Spain

218 participantsStarted 2023-03-15

Plain-language summary

Non-blinded randomized controlled non-inferiority trial to evaluate the feasibility, acceptability and impact of an innovative internet-accessed HIV and STIs screening intervention (TÉSTATE PrEP) addressed to gays, bisexuals and other men who have sex with men (GBMSM) and transgender women users of PrEP in Spain as part of PrEP follow up.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ≥18 years of age * GBMSM or transgender women * PrEP users with more than 1 year of follow up in the collaborating center (The Centre for International Health and Infectious Diseases Drassanes Vall d'Hebron (Barcelona)) * Not having altered renal function * Resident in Spain Exclusion Criteria: * Not able to read in Spanish * Not able to give their consent

What they're measuring

Retention to PrEP follow up

Timeframe: Two years follow-up (from baseline to year 2)

Healthcare burden

Timeframe: Two years follow-up (from baseline to year 2)

Trial details

NCT IDNCT05752643

SponsorFundació Institut Germans Trias i Pujol

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-30

View on ClinicalTrials.gov More HIV trials